Skip to main content
. 2022 Dec 3;14(12):2712. doi: 10.3390/pharmaceutics14122712

Figure 3.

Figure 3

Microneedle scaffold-based tumor-specific antigen delivery to the lymph node. (1–3) B cells encounter antigen and process it.